Brinter Is Well Positioned For Growth In The 3D Bioprinting Space


The founder and CEO of 3DHEALS, Jenny Chen, MD, has again used the grouping of public and private bioprinting companies into four categories (Newborns, Warriors, Unicorns, and Winners) in the 3D bioprinting space in her recent post at

She wrote that although, due to the pandemic, the year 2020 was a challenging year for the 3D printing industry as a whole, bioprinting companies still did incredibly well. Moreover, startups in healthcare 3D printing, bioprinting, and related 3D technologies are becoming more mature and more fundable. This trend is likely a result of the continued growth of the overall 3D printing industry, continued growth in healthcare technologies, as well as a more mature ecosystem that can support entrepreneurs in the space.

Jenny’s post provides some reviews and updates from both public and private 3D printing companies and the 3D bioprinting space. It also features Brinter as one of the Newborns, i.e. as an early-stage 3D startup founded in 2020. Deviating from Jenny’s writing on her post, Brinter actually has already secured 1.2 M€ as seed funding to pave the way to further expand its operations internationally in Europe and the US.